• Je něco špatně v tomto záznamu ?

Fluorinated 3,6,9-trisubstituted acridine derivatives as DNA interacting agents and topoisomerase inhibitors with A549 antiproliferative activity

P. Nunhart, E. Konkoľová, L. Janovec, R. Jendželovský, J. Vargová, J. Ševc, M. Matejová, B. Miltáková, P. Fedoročko, M. Kozurkova

. 2020 ; 94 (-) : 103393. [pub] 20191023

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21012938

A series of new 3,6,9-trisubstituted acridine derivatives with fluorine substituents on phenyl ring were synthesized and their interaction with calf thymus DNA was investigated. Analysis using UV-Vis absorbance spectra provided valuable information about the formation of the acridine-DNA complex. In addition, compounds 8b and 8d were found to display an increased binding affinity (K = 2.32 and 2.28 × 106 M-1, respectively). Topo I/II inhibition mode assays were also performed, and the results verify that the novel compounds display topoisomerase I and II inhibitory activity; compounds 8a, 8b and 8c completely inhibited topoisomerase I activity at a concentration of 60 × 10-6 M, but only compound 8d showed partial ability to inhibit topoisomerase II at concentrations of 30 and 50 × 10-6 M. The ability of the derivatives to impair cell proliferation was tested through an analysis of cell cycle distribution, quantification of cell number, viability studies, metabolic activity measurement and clonogenic assay. The content and localization of the derivatives in cells were analyzed using flow cytometry and fluorescence microscopy. The compounds 8b and 8d altered the physiochemical properties and improved antiproliferative activity in A549 human lung carcinoma cells (compound 8d displayed the highest level of activity, 4.25 × 10-6 M, after 48 h).

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012938
003      
CZ-PrNML
005      
20210507101651.0
007      
ta
008      
210420s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.bioorg.2019.103393 $2 doi
035    __
$a (PubMed)31679839
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Nunhart, Patrik $u Department of Biochemistry, Institute of Chemistry, Faculty of Science, P. J. Šafárik University in Košice, Šrobárova 2, 041 54 Košice, Slovak Republic
245    10
$a Fluorinated 3,6,9-trisubstituted acridine derivatives as DNA interacting agents and topoisomerase inhibitors with A549 antiproliferative activity / $c P. Nunhart, E. Konkoľová, L. Janovec, R. Jendželovský, J. Vargová, J. Ševc, M. Matejová, B. Miltáková, P. Fedoročko, M. Kozurkova
520    9_
$a A series of new 3,6,9-trisubstituted acridine derivatives with fluorine substituents on phenyl ring were synthesized and their interaction with calf thymus DNA was investigated. Analysis using UV-Vis absorbance spectra provided valuable information about the formation of the acridine-DNA complex. In addition, compounds 8b and 8d were found to display an increased binding affinity (K = 2.32 and 2.28 × 106 M-1, respectively). Topo I/II inhibition mode assays were also performed, and the results verify that the novel compounds display topoisomerase I and II inhibitory activity; compounds 8a, 8b and 8c completely inhibited topoisomerase I activity at a concentration of 60 × 10-6 M, but only compound 8d showed partial ability to inhibit topoisomerase II at concentrations of 30 and 50 × 10-6 M. The ability of the derivatives to impair cell proliferation was tested through an analysis of cell cycle distribution, quantification of cell number, viability studies, metabolic activity measurement and clonogenic assay. The content and localization of the derivatives in cells were analyzed using flow cytometry and fluorescence microscopy. The compounds 8b and 8d altered the physiochemical properties and improved antiproliferative activity in A549 human lung carcinoma cells (compound 8d displayed the highest level of activity, 4.25 × 10-6 M, after 48 h).
650    _2
$a buňky A549 $7 D000072283
650    _2
$a akridiny $x chemická syntéza $x chemie $x farmakologie $7 D000166
650    _2
$a zvířata $7 D000818
650    _2
$a protinádorové látky $x chemická syntéza $x chemie $x farmakologie $7 D000970
650    _2
$a skot $7 D002417
650    _2
$a proliferace buněk $x účinky léků $7 D049109
650    _2
$a DNA $x účinky léků $7 D004247
650    _2
$a DNA-topoisomerasy I $x metabolismus $7 D004264
650    _2
$a DNA-topoisomerasy typu II $x metabolismus $7 D004250
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a screeningové testy protinádorových léčiv $7 D004354
650    _2
$a halogenace $7 D054879
650    _2
$a lidé $7 D006801
650    _2
$a molekulární struktura $7 D015394
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
650    _2
$a inhibitory topoisomerasy I $x chemická syntéza $x chemie $x farmakologie $7 D059004
650    _2
$a inhibitory topoisomerasy II $x chemická syntéza $x chemie $x farmakologie $7 D059005
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Konkoľová, Eva $u Department of Biochemistry, Institute of Chemistry, Faculty of Science, P. J. Šafárik University in Košice, Šrobárova 2, 041 54 Košice, Slovak Republic
700    1_
$a Janovec, Ladislav $u Department of Organic Chemistry, Institute of Chemistry, Faculty of Science, P. J. Šafárik University in Košice, Šrobárova 2, 041 54 Košice, Slovak Republic
700    1_
$a Jendželovský, Rastislav $u Department of Cellular Biology, Institute of Biology and Ecology, Faculty of Science, P. J. Šafárik University in Košice, Šrobárova 2, 041 54 Košice, Slovak Republic
700    1_
$a Vargová, Jana $u Department of Cellular Biology, Institute of Biology and Ecology, Faculty of Science, P. J. Šafárik University in Košice, Šrobárova 2, 041 54 Košice, Slovak Republic
700    1_
$a Ševc, Juraj $u Department of Cellular Biology, Institute of Biology and Ecology, Faculty of Science, P. J. Šafárik University in Košice, Šrobárova 2, 041 54 Košice, Slovak Republic
700    1_
$a Matejová, Mária $u Department of Organic Chemistry, Institute of Chemistry, Faculty of Science, P. J. Šafárik University in Košice, Šrobárova 2, 041 54 Košice, Slovak Republic
700    1_
$a Miltáková, Beata $u Department of Organic Chemistry, Institute of Chemistry, Faculty of Science, P. J. Šafárik University in Košice, Šrobárova 2, 041 54 Košice, Slovak Republic
700    1_
$a Fedoročko, Peter $u Department of Cellular Biology, Institute of Biology and Ecology, Faculty of Science, P. J. Šafárik University in Košice, Šrobárova 2, 041 54 Košice, Slovak Republic
700    1_
$a Kozurkova, Mária $u Department of Biochemistry, Institute of Chemistry, Faculty of Science, P. J. Šafárik University in Košice, Šrobárova 2, 041 54 Košice, Slovak Republic; Biomedical Research Center, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. Electronic address: maria.kozurkova@upjs.sk
773    0_
$w MED00000771 $t Bioorganic chemistry $x 1090-2120 $g Roč. 94, č. - (2020), s. 103393
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31679839 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507101651 $b ABA008
999    __
$a ok $b bmc $g 1651170 $s 1133317
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 94 $c - $d 103393 $e 20191023 $i 1090-2120 $m Bioorganic chemistry $n Bioorg Chem $x MED00000771
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...